Impaired phenotype of circulating endothelial microparticles in chronic heart failure patients: Relevance to body mass index

Go, 2014, American Heart Association Statistics Committee and Stroke Statistics Subcommittee, executive summary: heart disease and stroke statistics – 2014 update: a report from the American Heart Association, Circulation, 129, 399, 10.1161/01.cir.0000442015.53336.12 Dunlay, 2014, Understanding the epidemic of heart failure: past, present, and future, Curr Heart Fail Rep, 11, 404, 10.1007/s11897-014-0220-x Gjesing, 2014, Nationwide trends in development of heart failure and mortality after first-time myocardial infarction 1997–2010: a Danish cohort study, Eur J Intern Med Dhingra, 2014, Epidemiology of heart failure with preserved ejection fraction, Curr Heart Fail Rep, 11, 354, 10.1007/s11897-014-0223-7 Chamberlain, 2014, Multimorbidity in heart failure: a community perspective, Am J Med, 128, 38 Bui, 2011, Epidemiology and risk profile of heart failure, Nat Rev Cardiol, 8, 30, 10.1038/nrcardio.2010.165 Roger, 2013, Epidemiology of heart failure, Circ Res, 113, 646, 10.1161/CIRCRESAHA.113.300268 Norton, 2011, Epidemiology and cost of advanced heart failure, Prog Cardiovasc Dis, 54, 78, 10.1016/j.pcad.2011.04.002 Owan, 2006, Trends in prevalence and outcome of heart failure with preserved ejection fraction, N Engl J Med, 355, 251, 10.1056/NEJMoa052256 Chan, 2013, How do patients with heart failure with preserved ejection fraction die?, Eur J Heart Fail, 15, 604, 10.1093/eurjhf/hft062 Kaila, 2012, Heart failure with preserved ejection fraction in the elderly: scope of the problem, Heart Fail Rev, 17, 555, 10.1007/s10741-011-9273-z Zhou, 2014, Natakalim improves post-infarction left ventricular remodeling by restoring the coordinated balance between endothelial function and cardiac hypertrophy, Int J Mol Med Tschöpe, 2014, New Insights in (inter)cellular mechanisms by heart failure with preserved ejection fraction, Curr Heart Fail Rep, 11, 436, 10.1007/s11897-014-0219-3 Wu, 2013, Membrane microparticles and diseases, Eur Rev Med Pharmacol Sci, 17, 2420 Berezin, 2014, Predictive value of apoptotic microparticles to mononuclear progenitor cells ratio in advanced chronic heart failure patients, J Cardiol (Jpn), 7, 438 Berezin, 2014, The biomarker risk prediction score in chronic heart failure, J Dis Markers, 1, 8 Barteneva, 2013, Circulating microparticles: square the circle, BMC Cell Biol, 14, 23, 10.1186/1471-2121-14-23 Tetta, 2011, The role of microvesicles in tissue repair, Organogenesis, 7, 105, 10.4161/org.7.2.15782 Martinez, 2011, Microparticles in angiogenesis: therapeutic potential, Circ Res, 109, 110, 10.1161/CIRCRESAHA.110.233049 Rautou, 2011, Microparticles, vascular function, and atherothrombosis, Circ Res, 109, 593, 10.1161/CIRCRESAHA.110.233163 Rahimi, 2014, Risk prediction in patients with heart failure: a systematic review and analysis, JACC Heart Fail, 2, 440, 10.1016/j.jchf.2014.04.008 Kishi, 2014, Association of obesity in early adulthood and middle age with incipient left ventricular dysfunction and structural remodeling: the CARDIA study (coronary artery risk development in young adults), JACC Heart Fail, 2, 500, 10.1016/j.jchf.2014.03.001 McMurray, 2012, ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012, Eur Heart J, 33, 1787, 10.1093/eurheartj/ehs104 Bluemke, 2008, Circulation, 118, 586, 10.1161/CIRCULATIONAHA.108.189695 Schiller, 1989, Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms, J Am Soc Echocardiogr, 2, 358, 10.1016/S0894-7317(89)80014-8 Pellerin, 2003, Tissue Doppler, strain, and strain rate echocardiography for the assessment of left and right systolic ventricular function, Heart, 89, iii9, 10.1136/heart.89.suppl_3.iii9 Levey, 2009, for the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate, Ann Intern Med, 150, 604, 10.7326/0003-4819-150-9-200905050-00006 Matthews, 1985, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28, 412, 10.1007/BF00280883 Friedewald, 1972, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, 18, 499, 10.1093/clinchem/18.6.499 Orozco, 2010, Flow cytometric analysis of circulating microparticles in plasma, Cytometry A, 77, 502, 10.1002/cyto.a.20886 Lacroix, 2013, The ISTH SSC workshop. Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop, J Thromb Haemost, 10.1111/jth.12207 Van Craenenbroeck, 2013, Mending injured endothelium in chronic heart failure: a new target for exercise training, Int J Cardiol, 166, 310, 10.1016/j.ijcard.2012.04.106 Garcia, 2005, Phenotypic assessment of endothelial microparticles in patients with heart failure and after heart transplantation: switch from cell activation to apoptosis, J Heart Lung Transplant, 24, 2184, 10.1016/j.healun.2005.07.006 Schiekofer, 2008, Angiogenic-regulatory network revealed by molecular profiling heart tissue following Akt1 induction in endothelial cells, Angiogenesis, 11, 289, 10.1007/s10456-008-9112-6 Markiewicz, 2013, Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases, J Aging Res, 2013, 734509, 10.1155/2013/734509 Berezin, 2014, Circulating endothelial-derived apoptotic microparticles in the patients with ischemic symptomatic chronic heart failure: relevance of pro-inflammatory activation and outcomes, Int Cardiovasc Res J, 8, 116 Montoro-García, 2013, Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes, Atherosclerosis, 227, 313, 10.1016/j.atherosclerosis.2013.01.028 Nozaki, 2009, Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease, J Am Coll Cardiol, 54, 601, 10.1016/j.jacc.2009.05.022 Nozaki, 2010, Prognostic value of endothelial microparticles in patients with heart failure, Eur J Heart Fail, 12, 1223, 10.1093/eurjhf/hfq145